Skip to content

Read-only version: For security reasons, the Research Information System (FIS) has been temporarily replaced by this read-only version. All public content and full texts remain available; login, editing, submission and statistics are not available. Questions: fis@uni-bamberg.de

Home › Publications › Relationship Between Lipohypertrophy, Glycemic Control, and Insulin Dosing : A Systematic Meta-Analysis

Publication

Relationship Between Lipohypertrophy, Glycemic Control, and Insulin Dosing : A Systematic Meta-Analysis

Mader, Julia K.; Fornengo, Ricardo; Hassoun, Ahmed; u. a. (2024): Relationship Between Lipohypertrophy, Glycemic Control, and Insulin Dosing : A Systematic Meta-Analysis, in: Diabetes Technology & Therapeutics, Larchmont, NY: Liebert, Jg. 26, Nr. 5, S. 351–362, doi: 10.1089/dia.2023.0491.

Details

Faculty/Chair
Faculty/Professorship
Author
Mader, Julia K.; Fornengo, Ricardo; Hassoun, Ahmed; Heinemann, Lutz; Kulzer, Bernhard; Monica, Magdalena; Nguyen, Trung; Sieber, Jochen; Renard, Eric; Reznik, Yves; Ryś, Przemysław; Stożek-Tutro, Anita; Wilmot, Emma G.
Title of the Journal
Diabetes Technology & Therapeutics
ISSN
1520-9156
Publisher Information
Liebert : Larchmont, NY
Year of publication
2024
Volume
26
Issue
5
Language
English
DOI
Abstract

Background: Lipohypertrophy is a common complication in patients with diabetes receiving insulin therapy. There is a lack of consensus regarding how much lipohypertrophy affects diabetes management. Our study aimed to assess the potential correlation between lipohypertrophy and glycemic control, as well as insulin dosing in patients with diabetes. Methods: We performed a systematic review followed by a meta-analysis to collect data about glycemic control and insulin dosing in diabetic patients with and without lipohypertrophy. To identify relevant studies published in English, we searched medical databases (MEDLINE/PubMed, Embase, and CENTRAL) from 1990 to January 20, 2023. An additional hand-search of references was performed to retrieve publications not indexed in medical databases. Results of meta-analyses were presented either as prevalence odds ratios (pORs) or mean differences (MDs) with 95% confidence intervals (95% CIs). This study was registered on PROSPERO (CRD42023393103). Results: Of the 5540 records and 240 full-text articles screened, 37 studies fulfilled the prespecified inclusion criteria. Performed meta-analyses showed that patients with lipohypertrophy compared with those without lipohypertrophy were more likely to experience unexplained hypoglycemia (pOR [95% CI] =6.98 [3.30– 14.77]), overall hypoglycemia (pOR [95% CI] =6.65 [1.37–32.36]), and glycemic variability (pOR [95%CI] =5.24 [2.68–10.23]). Patients with lipohypertrophy also had higher HbA1c (MD [95% CI] =0.55 [0.23–

0.87] %), and increased daily insulin consumption (MD [95% CI] =7.68 IU [5.31–10.06]). Conclusions: These results suggest that overall glycemic control is worse in patients with lipohypertrophy than in those without this condition.

Keywords
Keywords: Diabetes, Glycemic Control, Insulin-injection technique, Lipohypertrophy, Meta-analysis, Systematic review.
DDC Classification
150 Psychology
RVK Classification
CU 3000
Peer Reviewed
yes
International Distribution
yes
Open Access Journal
yes
Type
Article
URI
Activation date
2025-09-01

Permalink: https://fis.uni-bamberg.de/handle/uniba/109982 · Data as JSON · Cite: BibTeX · RIS

Data as of: 2026-11-15

Restricted read-only access: login, editing and submission are temporarily disabled.